- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
Neosar is a market of immune disorder drugs used to treat a variety of conditions, including autoimmune diseases, allergies, and asthma. These drugs are designed to reduce inflammation and suppress the immune system, allowing the body to heal itself. Neosar drugs are typically administered orally or intravenously, and can be used in combination with other treatments. Common side effects include nausea, headache, and fatigue.
The Neosar market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly innovating and developing new treatments to meet the needs of patients. Show Less Read more